Tech Company Financing Transactions
Zavante Therapeutics Funding Round
Zavante Therapeutics closed a $10 million funding round on 9/3/2016. Investors included Square 1 Bank.
Transaction Overview
Company Name
Announced On
9/3/2016
Transaction Type
Debt
Amount
$10,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds from the facility will provide growth capital to support commercialization efforts and the potential development of additional indications.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
12670 High Bluff Dr.
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Undisclosed
Website
Email Address
Overview
We are passionately committed to our mission to improve patients' lives by identifying, developing and commercializing novel therapeutics addressing significant unmet medical needs in the hospital setting.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ted Schroeder
Chief Financial Officer
Richard Vincent
Chief Operating Officer
Kevin Finney
Chief Scientific Officer
EJ Ellis-Grosse
VP - Manufacturing
Robert DiVasto
VP - Operations
David Skarinsky
VP - Regulatory Affairs
Kristina Haeckl
Browse more venture capital transactions:
Prev: 9/2/2016: Revuze venture capital transaction
Next: 9/3/2016: C3.ai venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs